×
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF
$ 40.00
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial PDF quantity
$ 40.00
×
The RAISE Early Treatment Program for First-Episode Psychosis: Background, Rationale, and Study Design PDF
$ 40.00
The RAISE Early Treatment Program for First-Episode Psychosis: Background, Rationale, and Study Design PDF quantity
$ 40.00
×
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis PDF
$ 40.00
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis PDF quantity
$ 40.00
×
Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review PDF
$ 40.00
Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review PDF quantity
$ 40.00
×
New-Onset Psychosis Secondary to COVID-19 Infection PDF
$ 40.00
New-Onset Psychosis Secondary to COVID-19 Infection PDF quantity
$ 40.00
×
Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report PDF
$ 40.00
Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
